Patients with prospective active disease progression had significantly higher frequencies of Eomes+ Th cells at baseline compared to stationary patients (P = 0.03; Fig. 5D), supporting a role of Eomes+ Th cells for prospective progression in SPMS. This evidence concerns the gene EOMES and secondary progressive multiple sclerosis.